Brisdelle receives FDA approval to treat hot flashes associated with menopause

FDA approves the first non-hormonal treatment for hot flashes associated with menopause The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the…

Source: Brisdelle receives FDA approval to treat hot flashes associated with menopause